Filament Health Corp. is a clinical-stage natural psychedelic drug development company, which engages in the discovery and development of natural psychedelic pharmaceuticals. It focuses on the discovery, development, and delivery of natural psychedelic medicines for clinical development. The company was founded by Benjamin Lightburn and Tom Kineshanko on June 8, 2020 and is headquartered in Burnaby, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company